In vivo magnetic resonance imaging of treatment-induced apoptosis

Area of Science:

• Oncology
• Medical Imaging
• Biophysics

Background:

• Accurate in vivo imaging of apoptosis is crucial for monitoring cancer treatment efficacy.
• Current molecular imaging methods for apoptosis lack widespread clinical acceptance and reliability.
• Cellular morphologic changes during apoptosis present a potential target for novel imaging techniques.

Purpose of the Study:

• To investigate the utility of temporal diffusion spectroscopy imaging (TDSI) for detecting and quantifying apoptosis.
• To assess TDSI's ability to identify cellular shrinkage, a key feature of apoptosis.
• To evaluate TDSI as a non-invasive method for monitoring tumor response to cetuximab treatment.

Main Methods:

• TDSI was employed to assess apoptosis in cetuximab-sensitive (DiFi) and insensitive (HCT-116) colorectal cancer cell lines in vitro and in vivo.
• TDSI findings were correlated with flow cytometry, cell cycle analysis, and immunohistochemistry.
• Morphological changes, specifically cell shrinkage, were quantified using TDSI parameters.

Main Results:

• TDSI successfully detected and quantified cell shrinkage associated with cetuximab-induced apoptosis in responsive cancer cells.
• Apoptotic cell shrinkage was observed in DiFi cells, confirmed by flow cytometry and histology.
• TDSI identified early cellular changes, including cell size reduction, preceding macroscopic tumor regression.

Conclusions:

• TDSI provides a unique, non-invasive measurement of apoptosis by detecting characteristic cellular changes like shrinkage.
• This imaging modality can aid in understanding tumor biology and predicting treatment response.
• TDSI's lack of exogenous agents or radiation makes it suitable for clinical integration.